MAP0004 Acute Migraine Medication Trial

Nancy Harris Bonk Living With It Community Manager My first real experience with chronic head pain... Send Message Subscribe: Nancy Harris Bonk

Friday, January 30, 2009
View All of Nancy Harris Bonk's Posts

MAP Pharmaceuticals recently completed patient enrollment in the efficacy (effectiveness) part of its initial Phase 3 clinical trial testing the orally inhaled MAP0004, used for acute Migraine attacks. 850 Migraineurs are evaluating the effectiveness and safety of M...

Hide Comments | Add comment

Nancy Brooks Treximet.
marie
Sunday, February 01, 2009 at 02:59 PM

Thanks for the information.

I live in canada. Is this in effect yet or only in the states?

re: Nancy Brooks Treximet.
Nancy Harris Bonk
Sunday, February 01, 2009 at 07:05 PM

MAP0004 is not available yet anywhere. This drug is still in its clinical trial stage.

Trexmet is available in the US, but I'm not sure about CA. I went to the Treximet site HERE but didn't see anything helpful about it being available in Canada. There are mail order pharmacies you may check into. Have you asked your pharmacist about Treximet?

Thanks!
Eileen Gray
Wednesday, February 04, 2009 at 05:33 PM

Great SP, Nancy! I look forward to having another medication available just for Migraine!

Thanks for the update on MAP0004!